198 related articles for article (PubMed ID: 36038627)
1. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.
Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q
Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627
[TBL] [Abstract][Full Text] [Related]
2. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
Pan WK; Ren SY; Zhu LX; Lin BC
Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164
[TBL] [Abstract][Full Text] [Related]
3. A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study.
Zhao W; Wu L; Zhao A; Zhang M; Tian Q; Shen Y; Wang F; Wang B; Wang L; Chen L; Zhao X; Dong D; Zhang L; Yang J
BMC Cancer; 2020 Oct; 20(1):982. PubMed ID: 33046035
[TBL] [Abstract][Full Text] [Related]
4. Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.
Sun W; Jiang YZ; Liu YR; Ma D; Shao ZM
Oncotarget; 2016 Apr; 7(15):20496-506. PubMed ID: 26967253
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age.
Cui X; Song D; Li X
Front Oncol; 2020; 10():636549. PubMed ID: 33628740
[TBL] [Abstract][Full Text] [Related]
6. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast Cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study.
Zhao J; Bian S; Di X; Xiao C
Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093
[TBL] [Abstract][Full Text] [Related]
7. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
8. Establishment and validation of nomograms to predict the overall survival and cancer-specific survival for non-metastatic bladder cancer patients: A large population-based cohort study and external validation.
Li S; Wang J; Zhang Z; Wu Y; Liu Z; Yin Z; Liu J; He D
Medicine (Baltimore); 2024 Mar; 103(11):e37492. PubMed ID: 38489693
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast.
Cheng Y; Zhang P; Huang Y; Zhang Z; Tang R; Chi F; Sun JY; He Z
BMJ Open; 2023 Feb; 13(2):e065312. PubMed ID: 36810178
[TBL] [Abstract][Full Text] [Related]
10. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
11. Nomograms for prediction of overall and cancer-specific survival in young breast cancer.
Sun Y; Li Y; Wu J; Tian H; Liu H; Fang Y; Li Y; Yu F
Breast Cancer Res Treat; 2020 Nov; 184(2):597-613. PubMed ID: 32886273
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
[TBL] [Abstract][Full Text] [Related]
13. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study.
Zhu H; Zhao S; Zhao T; Jiang K; Miao L; Jiang M; Wang F
Sci Rep; 2022 Apr; 12(1):5983. PubMed ID: 35396531
[TBL] [Abstract][Full Text] [Related]
15. Nomograms for predicting survival in patients with micropapillary bladder cancer: a real-world analysis based on the surveillance, epidemiology, and end results database and external validation in a tertiary center.
Liu P; Xu L; Chen G; Shi B; Zhang Q; Chen S
BMC Urol; 2023 Feb; 23(1):16. PubMed ID: 36782165
[TBL] [Abstract][Full Text] [Related]
16. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
17. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
18. Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.
Ding Y; Jiang R; Chen Y; Jing J; Yang X; Wu X; Zhang X; Xu J; Xu P; LiuHuang SC; Lu Z
BMC Cancer; 2021 Apr; 21(1):420. PubMed ID: 33863315
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer.
Guo LW; Jiang LM; Gong Y; Zhang HH; Li XG; He M; Sun WL; Ling H; Hu X
Cancer Manag Res; 2018; 10():5881-5894. PubMed ID: 30510456
[TBL] [Abstract][Full Text] [Related]
20. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
